Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mesa Laboratories (MLAB)
NASDAQ:MLAB
Holding MLAB?
Track your performance easily
MLAB Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$83.68 - $141.17
Previous Close$100.86
Volume63.43K
Average Volume (3M)35.05K
Market Cap
$547.81M
Enterprise Value$728.46M
Total Cash (Recent Filing)$24.34M
Total Debt (Recent Filing)$204.98M
Price to Earnings (P/E)―
Beta1.24
Next Earnings
Feb 10, 2025EPS Estimate
$1.91Next Dividend Ex-Date
Nov 29, 2024Dividend Yield0.65%
Share Statistics
EPS (TTM)-45.55
Shares Outstanding5,431,424
10 Day Avg. Volume38,919
30 Day Avg. Volume35,055
Standard Deviation0.12
R-Squared0.15
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)3.32
Price to Sales (P/S)2.37
Price to Cash Flow (P/CF)25.70
P/FCF Ratio38.90
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.19
Enterprise Value/Gross Profit5.47
Enterprise Value/Ebitda-3.13
Forecast
1Y Price Target
$135.00Price Target Upside23.75% Upside
Rating ConsensusHold
Number of Analyst Covering2
Mesa Laboratories News
PremiumCompany Announcements
Mesa Laboratories Reports Robust Q2 FY25 Results
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
MLAB FAQ
What was Mesa Laboratories’s price range in the past 12 months?
Mesa Laboratories lowest stock price was $83.68 and its highest was $141.17 in the past 12 months.
What is Mesa Laboratories’s market cap?
Currently, no data Available
When is Mesa Laboratories’s upcoming earnings report date?
Mesa Laboratories’s upcoming earnings report date is Feb 10, 2025 which is in 79 days.
How were Mesa Laboratories’s earnings last quarter?
Mesa Laboratories released its earnings results on Nov 07, 2024. The company reported $2.62 earnings per share for the quarter, beating the consensus estimate of $1.89 by $0.73.
Is Mesa Laboratories overvalued?
According to Wall Street analysts Mesa Laboratories’s price is currently Undervalued.
Does Mesa Laboratories pay dividends?
Mesa Laboratories pays a Quarterly dividend of $0.16 which represents an annual dividend yield of 0.65%. See more information on Mesa Laboratories dividends here
What is Mesa Laboratories’s EPS estimate?
Mesa Laboratories’s EPS estimate is $1.91.
How many shares outstanding does Mesa Laboratories have?
Mesa Laboratories has 5,431,424 shares outstanding.
What happened to Mesa Laboratories’s price movement after its last earnings report?
Mesa Laboratories reported an EPS of $2.62 in its last earnings report, beating expectations of $1.89. Following the earnings report the stock price went down -12.127%.
Which hedge fund is a major shareholder of Mesa Laboratories?
Among the largest hedge funds holding Mesa Laboratories’s share is Royce & Associates LLC. It holds Mesa Laboratories’s shares valued at 45M.
---
Mesa Laboratories Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$135.00 (23.75% Upside)
$135.00 (23.75% Upside)
Hedge Fund Trend
Decreased
By 31.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $571.7K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
14.58%
12-Months-Change
Fundamentals
Return on Equity
-89.46%
Trailing 12-Months
Asset Growth
-28.73%
Trailing 12-Months
Company Description
Mesa Laboratories
Mesa Laboratories, Inc. engages in the design, manufacture, and marketing of instruments and disposable products utilized in healthcare, pharmaceutical, food, and beverage, medical device, and petrochemical industries. It operates through the following segments: Sterilization and Disinfection, Instruments, Cold Chain Monitoring, and Cold Chain Packaging. The Sterilization and Disinfection segment offers testing services, along with the manufacturing and marketing of biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. The Instrument segment manufactures and markets control instruments and disposable products. The Cold Chain Monitoring segment designs, develops, and markets systems which are used to monitor environmental parameters such as temperature, humidity, and differential pressure. The Cold Chain Packaging segment provides consulting services including compliance monitoring, packaging development, and validation or mapping of transport and storage containers, and thermal packaging products. The company was founded by Luke R. Schmieder on March 26, 1982 and is headquartered in Lakewood, CO.
---
MLAB Stock 12 Month Forecast
Average Price Target
$135.00
▲(23.75% Upside)
Technical Analysis
Best Analysts Covering MLAB
1 Year
1 Year Success Rate
3/6 ratings generated profit
1 Year Average Return
-1.12%
initiated a sell rating 3 months ago
Copying Brandon Couillard's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of -1.12% per trade.
---